Please assess the completion status of the following clinical trial:

Trial Title: Low Dose Vasopressin in Traumatic Shock

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~To be eligible for enrollment in the study, a patient must meet all of the follow criteria at assessment:~* Patient is a male or female patient presumed to be at least 18 years of age;~* Patient has a systolic blood pressure \< 90 mmHg;~* Patient has clinical evidence of acute traumatic injury;~* Infusion of study drug must start within one hour following SBP (systolic blood pressure) \< 90 mmHg~Exclusion Criteria:~A patient meeting any one of the following criteria at hospital assessment is not eligible for enrollment:~* Patient is admitted to one of the study hospitals' Emergency Department greater than six hours after injury;~* Patient has received greater than 4 liters fluid since time of injury;~* Patient is enrolled in another shock trial;~* Patient is asystolic or requires CPR (cardiopulmonary resucitation) prior to randomization;~* Female patient is pregnant by report or suspicion;~* Patient has known Do Not Resuscitate orders or visible/identifiable method of objection to participation (e.g., exclusion bracelet);

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- I (Type: EXPERIMENTAL): Vasopressin
- 2 (Type: PLACEBO_COMPARATOR): bolus of NS (normal saline) followed by continuous infusion of NS, no vasopressin added

Based on this trial design, predict the completion outcome and termination type (if applicable).